Active substances

Ibandronic acid›

M05BA06 Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates

Indicated for: osteoporosis

Ibritumomab tiuxetan›

V10XX02 Various | Other therapeutic radiopharmaceuticals | Various therapeutic radiopharmaceuticals

Indicated for: lymphoma

Ibrutinib›

L01EL01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Bruton's tyrosine kinase (BTK) inhibitors

Indicated for: hematologic malignancies

Ibuprofen›

M01AE01 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives

Indicated for: pain and inflammation

Ibuprofen + caffeine›

M01AE51 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives

Indicated for: pain and inflammation

Ibuprofen + codeine›

N02AJ08 Nervous system | Opioids | Opioids in combination with non-opioid analgesics

Indicated for: pain and inflammation

Ibuprofen + levomenthol›

M02AX10 Musculo-skeletal system | Topical products for joint and muscular pain | Topical products for joint and muscular pain | Other topical products for joint and muscular pain

Indicated for: pain and inflammation

Ibuprofen + paracetamol›

M01AE52 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives

Indicated for: pain; fever

Ibuprofen + phenylephrine›

M01AE51 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives

Indicated for: pain and inflammation

Ibuprofen + pseudoephedrine›

R01BA52 Respiratory system | Nasal decongestants for systemic use | Sympathomimetics

Indicated for: pain and inflammation

Icatibant›

B06AC02 Blood and blood forming organs | Other hematological agents | Other hematological agents | Drugs used in hereditary angioedema

Indicated for: hereditary angioedema

Icodextrin›

B05DA Blood and blood forming organs | Peritoneal dialytics | Isotonic solutions

Indicated for: peritoneal dialysis

Icosapent ethyl›

C10AX06 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Other lipid modifying agents

Indicated for: hypertriglyceridemia; cardiovascular risk reduction

Idarubicin›

L01DB06 Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances

Indicated for: leukemia

Idarucizumab›

V03AB37 Various | All other therapeutic products | All other therapeutic products | Antidotes

Indicated for: reversal of anticoagulation

Idebenone›

N06BX13 Nervous system | Psychostimulants, agents used for adhd and nootropics | Other psychostimulants and nootropics

Indicated for: Leber hereditary optic neuropathy; Friedreich ataxia

Idelalisib›

L01EM01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Phosphatidylinositol-3-kinase (PI3K) inhibitors

Indicated for: hematologic malignancies

Idursulfase›

A16AB09 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: lysosomal enzyme deficiency

Ifosfamide›

L01AA06 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues

Indicated for: cancer

Iloprost›

B01AC11 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: pulmonary arterial hypertension

Imatinib›

L01EA01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Indicated for: chronic myeloid leukemia; gastrointestinal stromal tumors

Imidapril›

C09AA16 Cardiovascular system | Ace inhibitors, plain

Indicated for: hypertension

Imiglucerase›

A16AB02 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: Gaucher disease

Imipenem + cilastatin›

J01DH51 Antiinfectives for systemic use | Other beta-lactam antibacterials | Carbapenems

Indicated for: bacterial infections

Imipenem + cilastatin + relebactam›

J01DH56 Antiinfectives for systemic use | Other beta-lactam antibacterials | Carbapenems

Indicated for: bacterial infections

Imiquimod›

D06BB10 Dermatologicals | Chemotherapeutics for topical use | Antivirals

Indicated for: genital warts; actinic keratosis

Inactivated hepatitis A vaccine›

J07BC02 Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines

Indicated for: prevention of hepatitis A

Inactivated influenza vaccine›

J07BB02 Antiinfectives for systemic use | Viral vaccines | Influenza vaccines

Indicated for: prevention of influenza

Inactivated polio tetanus diphtheria vaccine›

J07CA01 Antiinfectives for systemic use | Bacterial and viral vaccines, combined

Indicated for: prevention of diphtheria, tetanus and pertussis

Inactivated tick-borne encephalitis vaccine›

J07BA01 Antiinfectives for systemic use | Viral vaccines | Encephalitis vaccines

Indicated for: prevention of tick-borne encephalitis